myProteus Limited Sustainability Profile
myProteus Limited, headquartered in Great Britain, is a leading innovator in the biotechnology sector, specialising in advanced proteomics and biomarker discovery. Founded in 2015, the company has rapidly established itself as a key player in the life sciences industry, with a focus on enhancing drug development and personalised medicine. With a strong presence in Europe and North America, myProteus offers unique services that leverage cutting-edge technologies to provide comprehensive proteomic analysis. Their core products, including proprietary software and analytical tools, are designed to deliver precise insights that drive research and clinical applications. Recognised for its commitment to quality and innovation, myProteus Limited has achieved significant milestones, positioning itself as a trusted partner for pharmaceutical companies and research institutions worldwide.
DitchCarbon Score
How does myProteus Limited's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
myProteus Limited's score of 26 is lower than 57% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
myProteus Limited's reported carbon emissions
myProteus Limited, headquartered in Great Britain, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that myProteus Limited may still be in the early stages of developing its climate commitments or may not have publicly disclosed its emissions profile. As the company navigates the evolving landscape of corporate sustainability, it may consider establishing measurable targets aligned with industry standards, such as those set by the Science Based Targets initiative (SBTi), to enhance its climate strategy. Engaging in initiatives like the Carbon Disclosure Project (CDP) or committing to renewable energy through RE100 could further strengthen its environmental commitments. In summary, myProteus Limited currently lacks specific emissions data and reduction initiatives, highlighting an opportunity for the company to develop a robust climate action plan in line with global sustainability efforts.
How Carbon Intensive is myProteus Limited's Industry?
How Carbon Intensive is myProteus Limited's Location?
myProteus Limited's Climate Goals (2030 & 2050)
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
myProteus Limited has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
